Access cutting-edge follicular lymphoma treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access follicular lymphoma specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related follicular lymphoma treatment provided free
The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).
Sponsor: Celgene
Check if you qualify for this follicular lymphoma clinical trial in Birmingham, AL
If you're searching for follicular lymphoma treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced follicular lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.